Arthneeti
VD

Vijaya Diagnost.

Q3 FY26Healthcare Services

Vijaya Diagnost. Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹1,483
Market cap₹15.5K Cr
P/E82.6
Updated26 Aug 2026
Read4 min read

The short version

Expecting to surpass Q4 revenue growth guidance of 15%, despite a non-flu season and limited seasonality (Page 14). Q4 FY26 expected to surpass 15% revenue growth guidance despite non-flu season and low seasonality (Siva Rama Raju).

From Vijaya Diagnost.'s Q3 FY26 earnings-call transcript · updated 26 Aug 2026.

Revenue & Sales Performance

  • Expecting to surpass Q4 revenue growth guidance of 15%, despite a non-flu season and limited seasonality (Page 14).
  • Wellness segment revenue typically increases in Q4, especially post mid-February to March-end, driven by corporate packages and health checkups (Page 14).
  • FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5).
  • Hub and spoke expansions ongoing: FY '27 to see 4-5 hubs and 10-12 spokes; FY '28-29 to have a balanced mix of hubs and spokes (Page 6).
  • Mature hubs (e.g., Hyderabad) continue organic volume growth of 10-15% (Page 6).
  • New geographies like West Bengal and Bangalore hubs have broken even early, indicating faster ramp-up and strong demand (Pages 8-13).

2 more points from Vijaya Diagnost.'s call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Vijaya Diagnost. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • FY '26 capex outlay utilized: INR 159 crores (including replacement capex).
  • FY '27 estimated capex plan for new centers: INR 100-120 crores.
  • Expansion plans for FY '27: 4-5 new hubs and 10-12 spokes.
  • FY '28 and '29 to see a balanced mix of hubs and spokes for optimal growth.
  • Focus on stabilizing current hubs before adding more, driven by operational bandwidth.
  • Investments ongoing in talent acquisition and digital/IT initiatives including high-end CRM, logistics app, cloud migration.

2 more points from Vijaya Diagnost.'s call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
1Health X Platform
Rev 1Mar 1
2Apollo Hospitals
Rev 2Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Vijaya Diagnost. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided transcript of Vijaya Diagnostic Centre Limited's Q3 FY26 earnings call does not explicitly mention details about the current or expected order book or pending orders. Key points discussed relate to: - Hub and spoke expansion plans for FY27 (4-5 hubs and 10-12 spokes) and beyond. - Focus on operational stability and organic growth in existing and new geographies.

2 more points from Vijaya Diagnost.'s call on order book

Pro opens every point from 15K+ earnings calls

Vijaya Diagnost. — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹219 Cr, net profit ₹48 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Vijaya Diagnostic Centre Ltd's management said in earlier quarters

Others in Healthcare Services this season

  • Chandan Healthcare Ltd (Q3 FY26)

    The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…

  • Rainbow Childrens Medicare Ltd (Q3 FY26)

    Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…

  • Krsnaa Diagnostics Ltd (Q3 FY26)

    Retail segment showing strong momentum, with retail revenue growing nearly 8x YoY in Q3 FY '26, contributing 8% of total revenue; network expanded to over…

  • Park Medi World Ltd (Q3 FY26)

    FY26 capex of ~INR 280 crores for Agra and Panchkula units; FY27 capex primarily for Kanpur and Delhi (~INR 110 crores). Key concall takeaways from Park Medi…

Compare:vs Apollo Hospitals Enterprise Ltdvs Fortis Health.vs Syngene International Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Vijaya Diagnost. and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Vijaya Diagnost. Q3 FY26 results?

Expecting to surpass Q4 revenue growth guidance of 15%, despite a non-flu season and limited seasonality (Page 14). Q4 FY26 expected to surpass 15% revenue growth guidance despite non-flu season and low seasonality (Siva Rama Raju).

What is Vijaya Diagnost. share price analysis?

Vijaya Diagnost. currently shows a neutral. The stock trades at a P/E of 82.6 with a market cap of ₹15,495 Cr. Investors should review the full earnings analysis for detailed insights.

Is Vijaya Diagnost. planning capital expenditure?

FY '26 capex outlay utilized: INR 159 crores (including replacement capex).

Keep Vijaya Diagnost. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.